Yuhan Corporation (KRX:000100)

South Korea flag South Korea · Delayed Price · Currency is KRW
93,700
-400 (-0.43%)
At close: Apr 28, 2026
-18.52%
Market Cap 6.96T
Revenue (ttm) 2.19T
Net Income (ttm) 194.08B
Shares Out 74.44M
EPS (ttm) 2,599.51
PE Ratio 36.05
Forward PE 43.43
Dividend 500.00 (0.53%)
Ex-Dividend Date Feb 26, 2026
Volume 200,397
Average Volume 188,032
Open 94,200
Previous Close 94,100
Day's Range 93,600 - 94,500
52-Week Range 90,900 - 136,400
Beta 0.57
RSI 42.82
Earnings Date May 15, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Sector Healthcare
Founded 1926
Employees 2,067
Stock Exchange Korea Stock Exchange
Ticker Symbol 000100
Full Company Profile

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 194.08 billion, an increase of 174.56%.

Financial Statements

News

There is no news available yet.